M. Zimbric

Sputum Metabolites Associated with Nontuberculous Mycobacterial Infection in Cystic Fibrosis

P. Breen, K. Opron, L. Caverly, 2022, mSphere.

Cystic fibrosis airway microbiota associated with outcomes of nontuberculous mycobacterial infection

J. Lipuma, K. Opron, L. Caverly, 2021, ERJ Open Research.

Distribution and outcomes of infection of Mycobacterium avium complex species in cystic fibrosis.

K. Shedden, L. Caverly, M. Azar, 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Sputum Metabolites Associated with Nontuberculous Mycobacterial Infection in Cystic Fibrosis

P. Breen, K. Opron, L. Caverly, 2022, mSphere.

Outcomes of cystic fibrosis pulmonary exacerbations treated with antibiotics with activity against anaerobic bacteria.

Corey Powell, L. Caverly, S. Cahalan, 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Genomic Analyses of Longitudinal Mycobacterium abscessus Isolates in a Multi-Center Cohort Reveal Parallel Signatures of In-Host Adaptation.

G. Dantas, M. Wallace, S. Fishbein, 2023, Journal of Infectious Diseases.

Itaconic acid inhibits nontuberculous mycobacterial growth in pH dependent manner while 4-octyl-itaconic acid enhances THP-1 clearance of nontuberculous mycobacteria in vitro

M. Zimbric, Paul Breen, Lindsay J Caverly, 2024, PloS one.